Gene · 1048
Papers3,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application of Biosensors in Detecting Breast Cancer Metastasis. | Sensors (Basel) | 2023 | 37960513 | PubTator, text mining | PubMed |
| Preliminary Evaluation Salivary Biomarkers in Patients with Oral Potentially Malignant Disorders (OPMD): A Case-Control Study. | Cancers (Basel) | 2023 | 37958429 | PubTator, text mining | PubMed |
| Artificial Intelligence and Lung Cancer: Impact on Improving Patient Outcomes. | Cancers (Basel) | 2023 | 37958411 | PubTator, text mining | PubMed |
| Clinical and Paraclinical Characteristics of Endobronchial Pulmonary Squamous Cell Carcinoma-A Brief Review. | Diagnostics (Basel) | 2023 | 37958213 | PubTator, text mining | PubMed |
| The Imageable Genome. | Nat Commun | 2023 | 37957176 | PubTator, text mining | PubMed |
| An integrated study to decipher immunosuppressive cellular communication in the PDAC environment. | NPJ Syst Biol Appl | 2023 | 37945567 | PubTator, text mining | PubMed |
| Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application. | Cell Rep Med | 2023 | 37944531 | PubTator, text mining | PubMed |
| Co-existing pericardial and pleural malignant mesothelioma responding well to nedaplatin and pemetrexed: a case report. | AME Case Rep | 2023 | 37942039 | PubTator, text mining | PubMed |
| Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy. | Ann Med | 2023 | 37939258 | PubTator, text mining | PubMed |
| Nodular scalp mass as the first presentation of pulmonary large cell neuroendocrine carcinoma: a case report. | Arch Craniofac Surg | 2023 | 37919912 | PubTator, text mining | PubMed |
| A sensitive and robust plasma-based DNA methylation panel for early detection of target gastrointestinal cancers. | Neoplasia | 2023 | 37918207 | PubTator, text mining | PubMed |
| Engineered small extracellular vesicles as a novel platform to suppress human oncovirus-associated cancers. | Infect Agent Cancer | 2023 | 37915098 | PubTator, text mining | PubMed |
| Analysis of gastrin-17 and its related influencing factors in physical examination results. | Immun Inflamm Dis | 2023 | 37904688 | PubTator, text mining | PubMed |
| Biological function and clinical application prospect of tsRNAs in digestive system biology and pathology. | Cell Commun Signal | 2023 | 37904174 | PubTator, text mining | PubMed |
| Prognostic factors in patients with high-risk stage II colon cancer after curative resection: a post hoc analysis of the JFMC46-1201 trial. | Int J Colorectal Dis | 2023 | 37903983 | PubTator, text mining | PubMed |
| Unraveling DPP4 Receptor Interactions with SARS-CoV-2 Variants and MERS-CoV: Insights into Pulmonary Disorders via Immunoinformatics and Molecular Dynamics. | Viruses | 2023 | 37896834 | PubTator, text mining | PubMed |
| Bispecific Antibodies in Lung Cancer: A State-of-the-Art Review. | Pharmaceuticals (Basel) | 2023 | 37895932 | PubTator, text mining | PubMed |
| Unlocking the Potential of the CA2, CA7, and ITM2C Gene Signatures for the Early Detection of Colorectal Cancer: A Comprehensive Analysis of RNA-Seq Data by Utilizing Machine Learning Algorithms. | Genes (Basel) | 2023 | 37895185 | PubTator, text mining | PubMed |
| Unveiling the Immune Microenvironment's Role in Breast Cancer: A Glimpse into Promising Frontiers. | Int J Mol Sci | 2023 | 37895012 | PubTator, text mining | PubMed |
| Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies. | Cancers (Basel) | 2023 | 37894314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1048/papers?page=17